These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12422642)

  • 1. [Effect of levofloxacine on cell elements of the lung tissue and on the growth of drug resistant Mycobacteria tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD
    Antibiot Khimioter; 2002; 47(6):12-7. PubMed ID: 12422642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of levofloxacin antitubercular activity in vitro and in lung tissue culture].
    Sokolova GB; Kunichan AD; Litovchenko KV; Tsybanev AA
    Antibiot Khimioter; 2002; 47(12):15-9. PubMed ID: 12728630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A whole blood bactericidal assay for tuberculosis.
    Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
    J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
    Kunichan AD; Sokolova GB; Shapatava MN
    Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an intracellular pharmacokinetic in vitro infection model as a tool to assess tuberculosis therapy.
    Cappelletty DM
    Int J Antimicrob Agents; 2007 Feb; 29(2):212-6. PubMed ID: 17204402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
    Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Herbert D; Paramasivan CN; Venkatesan P; Kubendiran G; Prabhakar R; Mitchison DA
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2296-9. PubMed ID: 8891133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of a line probe assay kit for the identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis].
    Matsumoto T; Ogata H; Toyota E; Suzuki K; Saito T; Fujita A; Suetake T; Chikamatsu K; Mizuno K; Mitarai S
    Kekkaku; 2013 Mar; 88(3):291-6. PubMed ID: 23672169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of Mycobacterium tuberculosis to levofloxacin].
    Vishnevskiĭ BI; Istomin EA; Miakotina EN
    Antibiot Khimioter; 2002; 47(6):28-30. PubMed ID: 12422645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of minimum bactericidal concentration, in single or combination drugs, against
    Santos NCS; Scodro RBL; Leal DC; do Prado SM; Micheletti DF; Sampiron EG; Costacurta GF; de Almeida AL; da Silva LA; Ieque AL; Ghiraldi Lopes LD; de Pádua RA; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF
    Future Microbiol; 2020 Jan; 15():107-114. PubMed ID: 32064924
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.
    Akcali S; Surucuoglu S; Cicek C; Ozbakkaloglu B
    Ann Saudi Med; 2005; 25(5):409-12. PubMed ID: 16270765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
    JI B; Lounis N; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1341-4. PubMed ID: 7574527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture.
    Janulionis E; Sofer C; Song HY; Wallis RS
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3133-5. PubMed ID: 15273133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.